Key result
Home prothrombin time monitoring boosts time in therapeutic range by ~18 percentage points vs clinic care.
Why the study?
The efficacy and accuracy of monitoring prothrombin times at home after starting warfarin therapy needed evaluation.
Does home prothrombin time monitoring improve time in therapeutic range compared to specialized clinic care in patients initiating warfarin?
RCT (n=50)
Randomized
Yes
Does home prothrombin time monitoring improve time in therapeutic range compared to specialized clinic care in patients initiating warfarin?
Home prothrombin time monitoring is feasible, accurate, and provides superior anticoagulation control compared to standard clinic care for patients initiating warfarin.
Answers are grounded in this paper and cite their sources.
Home monitoring improves TTR in warfarin initiators; supports adoption and extends self-monitoring evidence.
Study objective To evaluate the efficacy and accuracy of monitoring prothrombin times at home. Design Randomized, prospective cohort study. Setting Outpatients discharged from a university hospital or a community hospital. Patients Fifty patients started on warfarin for the first time who demonstrated an ability to use the monitor and who had not achieved a stable response to warfarin in the hospital. Intervention Oral anticoagulation therapy managed using a portable prothrombin time monitor compared with specialized anticoagulation clinic care. Measurements and main results In the 46 patients who completed the 8-week study, the median percentage of time that patients in the home-monitor group (n = 23) were within a range equal to the target prothrombin ratio +/- 0.3, but always above 1.25, was 93%, compared with 75% for patients in the clinic group (n = 23) (P = 0.003). There was no significant difference between groups in the percentage of time above the therapeutic range; however, the percentage of time that patients were subtherapeutic was significantly greater in the clinic group (P less than 0.001). There were no major thromboembolic or hemorrhagic complications in either group. Differences between home monitor measurements and corresponding clinical laboratory measurements using blood samples drawn within 4 hours of the home test were comparable to differences observed between measurements using two different clinical laboratory instruments. Conclusions Use of a portable prothrombin time monitor by patients at home is feasible and provides accurate measurements. Patients doing home monitoring achieve superior anticoagulation control compared with those receiving standard anticoagulation clinic care.
No takes yet. Share an insight, caveat, or question.
Richard H. White (1989) conducted an RCT in Initiation of warfarin therapy (n=50). Home prothrombin time monitoring vs. Specialized anticoagulation clinic care was evaluated on Median percentage of time within target prothrombin ratio range (+/- 0.3, always >1.25) (p=0.003). Home prothrombin time monitoring achieved superior anticoagulation control vs clinic care, with median time in therapeutic range.
Synapse has enriched 10 related papers. Consider them for comparative context: